| 前收市價 | 9.16 |
| 開市 | 9.34 |
| 買盤 | 9.37 x 105300 |
| 賣出價 | 9.38 x 169300 |
| 今日波幅 | 9.10 - 9.57 |
| 52 週波幅 | 8.52 - 24.44 |
| 成交量 | |
| 平均成交量 | 1,173,990 |
| 市值 | 1.636B |
| Beta 值 (5 年，每月) | 1.11 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.47 |
| 業績公佈日 | 2024年5月22日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 26.00 |
Insider MonkeyEvotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript
Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript April 24, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333. Evotec SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to […]
BenzingaLife Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
European life science company Evotec SE (NASDAQ:EVO) announced a priority reset to optimize its business to meet evolving market demand and focus on profitable growth in 2024 and beyond. The company is focusing on and rightsizing organizations to overcome the challenging market environment and return to sustainable and profitable growth. Shared R&D and Just–Evotec Biologics will replace EVT Execute & EVT Innovate segments in a streamlined reporting structure as of Q1 2024. The priority reset is
InvestorPlaceFinding the Next Big Winners: 7 Stocks You Can Snag for Under $10
If you’re on the hunt for stocks under $10, look no further. The stock market has been off to a scorching start in 2024. Indexes have been going virtually straight up and momentum stocks are flying. With the economy remaining strong and the Federal Reserve potentially set to cut interest rates, this is seemingly a best of all worlds scenario for the equity market. The enthusiasm is understandable. But it does leave some investors wondering where the bargains are. After such a huge run in the maj
